Your browser doesn't support javascript.
loading
Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of using a S···O binding interaction for drug design.
Liu, Chunjian; Wang, Wei; Feng, Jianxin; Beno, Brett; Raja, Thiruvenkadam; Swidorski, Jacob; Manepalli, Raju K V L P; Vetrichelvan, Muthalagu; Rao Jalagam, Prasada; Nair, Satheesh K; Gupta, Anuradha; Panda, Manoranjan; Ghosh, Kaushik; Kaushikkumar Shukla, Jinal; Sale, Harinath; Shah, Devang; Singh Gautam, Shashyendra; Patel, Dipal; Mathur, Arvind; Ellsworth, Bruce A; Cheng, Dong; Regueiro-Ren, Alicia.
Afiliação
  • Liu C; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States. Electronic address: chunjian.liu@bms.com.
  • Wang W; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
  • Feng J; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
  • Beno B; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
  • Raja T; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Swidorski J; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
  • Manepalli RKVLP; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Vetrichelvan M; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Rao Jalagam P; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Nair SK; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Gupta A; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Panda M; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Ghosh K; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Kaushikkumar Shukla J; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Sale H; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Shah D; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Singh Gautam S; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Patel D; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
  • Mathur A; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
  • Ellsworth BA; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
  • Cheng D; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
  • Regueiro-Ren A; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Bioorg Med Chem ; 101: 117638, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-38394996
ABSTRACT
As a result of our continued efforts to pursue Gal-3 inhibitors that could be used to fully evaluate the potential of Gal-3 as a therapeutic target, two novel series of benzothiazole derived monosaccharides as potent (against both human and mouse Gal-3) and orally bioavailable Gal-3 inhibitors, represented by 4 and 5, respectively, were identified. These discoveries were made based on proposals that the benzothiazole sulfur atom could interact with the carbonyl oxygen of G182/G196 in h/mGal-3, and that the anomeric triazole moiety could be modified into an N-methyl carboxamide functionality. The interaction between the benzothiazole sulfur and the carbonyl oxygen of G196 in mGal-3 was confirmed by an X-ray co-crystal structure of early lead 9, providing a rare example of using a S···O binding interaction for drug design. It was found that for both the series, methylation of 3-OH in the monosaccharides caused no loss in h & mGal-3 potencies but significantly improved permeability of the molecules.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Galectina 3 / Monossacarídeos Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Galectina 3 / Monossacarídeos Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2024 Tipo de documento: Article
...